Skip to main content
  • COVID-19
    • COVID-19 vaccines and cancer
      • FAQs
      • FAQs in-language
      • SerOzNET Study
    • COVID-19 information for people affected by cancer
      • Managing your cancer care in the context of COVID-19
      • Looking after your mental wellbeing
      • Canada
      • Ireland
      • UK
      • USA
    • COVID-19 information for children and young people with cancer
    • Cancer Won’t Wait
    • Cancer and COVID-19 - what it means for our Mob
      • COVID-19 vaccines: Information for Aboriginal and Torres Strait Islander people affected by cancer
      • Act early for our Mob's health
    • Guidance for health professionals
      • Diagnosis
      • Treatment
      • Surgery
      • Medical oncology
      • Radiation oncology
      • Primary care
      • Telehealth
      • Clinical trials
      • Follow-up care
      • Supportive and Palliative care
      • Cancer care for cancer patients with COVID-19
      • COVID-19 vaccines and cancer
      • Recovery
    • Research articles
      • Review articles
      • Data articles
      • Recommendations articles
      • Shared experience articles
      • COVID-19 vaccines and cancer articles
    • Cancer care in the time of COVID-19: A conceptual framework
    • Optimal cancer care during the COVID-19 pandemic: the Principles
    • The impact of COVID-19 on cancer services
    • COVID-19 Recovery: Implications for cancer care
      • Expanded use of telehealth
      • Changes to prevention and early detection
      • Virtual multidisciplinary team meetings
      • Modifications to treatment schedules
      • Hypofractionated radiotherapy
      • Oncology hospital in the home
      • Responsive patient support
      • Innovative care and hospital infrastructure models
      • Shared follow-up and survivorship care
      • Supportive and palliative care
      • Cancer research and clinical trials
      • Collaboration in the oncology sector and data sharing
      • Acknowledgements
  • About us
    • Organisational structure
    • Accountability and reporting
      • Annual reports
    • Who we work with
      • Roles & functions
      • Advisory Council
      • Advisory groups
      • Consumer engagement
      • Government cancer control organisations
    • Information publication scheme
      • Information publication scheme plan
      • Freedom of information act
        • The FOI request process
      • FOI disclosure log
    • Reconciliation action plan
    • Employment opportunities
  • News and media
    • News
    • Subscribe to our eNewsletter
  • Contact us
Cancer Australia
Choose Language
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • Home
  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives
  • Home
  • Cancer types
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children’s cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary cancer
    • Uterine sarcoma
    • Vaginal cancer
    • Vulvar cancer
  • Impacted by Cancer
    • What is cancer
    • Physical changes
    • Treatment
    • Keeping healthy
    • Emotions
    • Family and relationships
    • Living with cancer
    • Lynch Syndrome
  • Awareness
    • Your cancer risk
    • Screening
    • Interactive body map
  • Research
    • Cancer Research in Australia
    • Data and statistics
    • Australian Clinical Trials
    • Support for cancer clinical trials
    • Grants and funding
  • Resources
    • Cancer Australia Publications
    • Clinical Practice Guidelines
    • Position statements
    • Resources in other languages
    • Cancer Australia websites
    • Cancer risk online assessment tools
    • Other tools and resources
    • Podcasts
    • Cancer support organisations
    • Glossary
  • Clinicians hub
    • GP guides and resources
    • Guidelines by cancer type
    • Optimal Care pathways
    • Working with Aboriginal and Torres Strait Islander people
    • Multidisciplinary care
    • Psychosocial care
    • Follow-up care
    • Family cancer clinics
    • Cancer Learning
    • Consumer engagement
  • Key initiatives
    • For Aboriginal and Torres Strait Islander people
    • Australian Cancer Plan
    • Australian Brain Cancer Mission
    • Lung Cancer Screening
    • National Pancreatic Cancer Roadmap
    • Campaigns & events
    • Jeannie Ferris Recognition Award

Liver cancer

liver-mm cancer-types/liver-cancer/overview
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
  1. Home
  2. Treatment
Loading...

Treatment options

  • Printer-friendly version
  • A|A

Treatment and care of people with cancer is usually provided by a team of health professionals, both medical and allied health, called a multidisciplinary team.

Treatment for liver cancer depends on:

•       the stage of the disease

•       the severity of symptoms

•       whether you have cirrhosis

•       your wishes and preferences

•       your general health.

Treatment may involve the following.

Surveillance

If the liver tumour is very small, treatment may not be recommended straight away. This is called ‘surveillance’. You may need to have follow-up appointments every 3 months to make sure the cancer is not growing.

Surgery

There are many kinds of surgery to treat liver cancer. The type of surgery you have depends on the size of the tumour, how many tumours there are, where they are located, and if you have cirrhosis.

Liver resection

If your liver is working well (for example, if you have no or early cirrhosis), you might have surgery to remove the cancer from the liver, as well as some healthy tissue around the cancer. This is called a liver resection or partial hepatectomy. Your liver must be working well as it needs to repair itself after the procedure.

There are different types of liver resection, depending on the cancer’s size and location. These include:

•       right or left hepatectomy – this removes the right or left part of the liver; in an extended right or left hepatectomy, most of the liver is removed

•       segmentectomy – this removes a small section of the liver

The gall bladder may also be removed, as well as the diaphragm (the muscle that separates the chest from the abdomen).

Liver resection is done under general anaesthetic in a hospital. It can be:

•       open surgery – where an incision (cut) is made in your upper abdomen

•       laparoscopic surgery (called ‘keyhole’ surgery) – where several small cuts are made in your abdomen and the cancer is removed using special surgical instruments.

After surgery, the liver that remains in your body will start to grow. It usually takes a few months for the liver to regrow to its normal size, but its shape may be different.

Portal vein embolisation

If there won’t be enough of your liver left after surgery to recover, you may have a portal vein embolisation (PVE). This is done about 4–8 weeks before your liver resection.

The liver receives blood from the portal vein, which branches into the left and right part of the liver.

A catheter is inserted into the portal vein that leads to the cancerous part of the liver (the part that will be removed). Tiny plastic beads, soft gel sponges or metal coils are inserted into the vein through the catheter. These block blood flow to the damaged part of the liver, which causes the other part of the liver (the part that won’t be removed) to get bigger.

If your liver has grown enough, you will then have a liver resection.

Liver transplant

A liver transplant is where the whole diseased liver is removed and replaced with a healthy liver from a donor. This may be done when the disease is in the liver only. You can also just have a portion of your liver replaced.

To be eligible for a liver transplant, you need to be reasonably fit, not smoke or take drugs, and have not drunk alcohol for at least 6 months.

After a liver transplant, you will need to take drugs called immunosuppressants. These stop your body from rejecting the new liver. These need to be taken for the rest of your life.

Tumour ablation

If your primary liver tumour is small and surgery is not an option, you may have tumour ablation. This destroys the tumour without needing to remove it.

The type of ablation you have depends on the size, shape and location of the tumour. They include:

•       thermal ablation, which uses heat to destroy the tumour – a fine needle inserted into the tumour sends out radio waves (called radiofrequency ablation) or microwaves (called microwave ablation) that produce heat and destroy the liver cancer cells

•       Alcohol injection, where pure alcohol is injected into the tumour

•       Cryotherapy (also called cryosurgery), which destroys the cancer cells by freezing them – a probe that gets very cold is inserted into the tumour.

Side effects of tumour ablation may include pain or fever, but these can be managed with medicines.

Transarterial chemoembolisation

If you can’t have surgery or are waiting for a liver transplant, you may have transarterial chemoembolisation (TACE). This is a way of delivering high doses of chemotherapy directly to the tumour while also blocking its blood supply (embolisation).

A catheter will be passed through a small cut in your groin into the hepatic artery (a blood vessel that supplies oxygenated blood to the liver). The chemotherapy drugs are injected into the liver through the catheter. Tiny plastic beads or soft gel sponges are also injected to block the blood supply to the cancer. This may stop the cancer from growing, or even cause it to shrink.

Common side effects of TACE treatment include fever, pain, tiredness and flu-like symptoms, but these usually pass quickly or can be managed with medicines.

Radiation therapy

There are 2 types of radiation therapy that may be used to treat liver cancer:

•       Selective internal radiation therapy (SIRT), also known as radioembolisation: small radioactive beads are inserted into the hepatic artery to target the cancer with high doses of radiation; this may be used when surgery is not an option, or to shrink the tumour before surgery or a liver transplant

•       Stereotactic body radiation therapy (SBRT): a machine directs focused beams of high-dose radiation at the liver tumour; this may be used when surgery, tumour ablation or TACE are not possible, or to shrink tumours before a liver transplant.

Targeted therapy

Targeted therapy refers to treatment with medicines that are designed to specifically attack cancer cells without harming normal cells. These types of medicines affect the way that cancer cells grow, divide, repair themselves or interact with other cells.

Medicines used for targeted therapy of liver cancer include sorafenib or lenvatinib. These are tyrosine kinase inhibitors that block signals the cancer cells need to grow and divide.

Side effects of these medicines may include:

•       skin rash

•       diarrhoea

•       high blood pressure

•       fatigue.

Immunotherapy

Immunotherapy uses medicines to stimulate the immune system to attack cancer cells.

Immune checkpoint inhibitors block proteins on immune system cells that stop these cells from attacking other cells in the body. This can help boost the immune system’s response against cancer cells. Types of immune checkpoint inhibitors used for liver cancer treatment include:

•       atezolizumab

•       pembrolizumab

•       nivolumab

•       ipilimumab.

Side effects of these type of drugs include:

•       feeling weak or tired

•       fever

•       nausea and loss of appetite

•       skin rash

•       muscle or joint pain.

Treatment for secondary cancer in the liver

Secondary cancer in the liver is cancer that has spread (or metastasised) to the liver from another part of the body. Secondary cancer in the liver is much more common than primary liver cancer in Australia.

Treatment for secondary cancer in the liver depends on where the original cancer started, the size and number of tumours, and your age and general health. The main treatment is chemotherapy, or a combination of surgery and chemotherapy. You may also receive radiation therapy or targeted therapy.

Follow-up

After treatment, you might have regular visits with your doctor for physical examinations, blood tests, X-rays or scans. These show if your condition has changed or if the cancer has recurred (come back).

You should let your doctor know if you notice any symptoms between appointments.

Recurrent cancer

Primary liver cancer can come back (recur) after treatment. If liver cancer has come back, the treatment you have will depend on the type of cancer, where it has spread, the type of treatments you have already had and your general health.

 
  • Last Updated
  • Relevant Links
updated: 4 November 2022 - 3:12pm
Pancare Foundation
Cancer Council Australia
Liver Foundation
Australian Cancer Trials

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2023 - Cancer Australia